Nacubactam has some intrinsic antibacterial exercise because of PBP2 inhibition [141]. It appears to acquire significant in vivo action against AmpC-overproducing and Klebsiella pneumoniae In summary cefiderocol, thanks to its sturdy activity as well as the higher susceptibility of DTR P. aeruginosa MICs of cefepime/zidebactam were reviewed in this article https://devincilsv.newbigblog.com/34243183/selnoflast-options